Cargando…
Effect of Coenzyme Q(10) on Insulin Resistance in Korean Patients with Prediabetes: A Pilot Single-Center, Randomized, Double-Blind, Placebo-Controlled Study
INTRODUCTION: This study aimed to examine whether administration of coenzyme Q10, an antioxidant, improves insulin resistance in patients with prediabetes. The study design was a pilot single-center, randomized, double-blind, placebo-controlled trial. METHODS: This pilot single-center, randomized, d...
Autores principales: | Yoo, Ja-Young, Yum, Keun-Sang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087610/ https://www.ncbi.nlm.nih.gov/pubmed/30151373 http://dx.doi.org/10.1155/2018/1613247 |
Ejemplares similares
-
Coenzyme Q10 Supplementation in Statin Treated Patients: A Double-Blinded Randomized Placebo-Controlled Trial
por: Dohlmann, Tine L., et al.
Publicado: (2022) -
Ubiquinol (reduced Coenzyme Q10) in patients with severe sepsis or septic shock: a randomized, double-blind, placebo-controlled, pilot trial
por: Donnino, Michael W., et al.
Publicado: (2015) -
Coenzyme Q10 in the Treatment of Heart Failure with Preserved Ejection Fraction: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
por: Samuel, Tal Y., et al.
Publicado: (2021) -
Combination of atorvastatin/coenzyme Q10 as adjunctive treatment in congestive heart failure: A double-blind randomized
placebo-controlled clinical trial
por: Pourmoghaddas, Masoud, et al.
Publicado: (2014) -
Coenzyme q10 liquid supplementation in dyslipidemic subjects with statin-related clinical symptoms: a double-blind, randomized, placebo-controlled study
por: Derosa, Giuseppe, et al.
Publicado: (2019)